Published in J Clin Oncol on September 01, 1998
Dose-Dense Chemotherapy: Principles, Clinical Results and Future Perspectives. Breast Care (Basel) (2008) 1.03
Neutropenic event risk and impaired chemotherapy delivery in six European audits of breast cancer treatment. Support Care Cancer (2006) 1.00
Relative dose intensity delivered to patients with early breast cancer: Canadian experience. Curr Oncol (2009) 0.80
High-dose sequential epirubicin and cyclophosphamide with peripheral blood stem cell support for advanced breast cancer: results of a phase II study. Br J Cancer (2001) 0.78
A 4-week versus a 3-week schedule of gemcitabine monotherapy for advanced pancreatic cancer: a randomized phase II study to evaluate toxicity and dose intensity. Int J Clin Oncol (2011) 0.76
Modeling Tumor Clonal Evolution for Drug Combinations Design. Trends Cancer (2016) 0.75
Nanoparticle albumin-bound paclitaxel in a patient with locally advanced breast cancer and taxane-induced skin toxicity: a case report. J Med Case Rep (2014) 0.75
Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat Genet (2000) 8.58
Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B. N Engl J Med (1994) 5.03
Racial differences in the incidence of cardiac arrest and subsequent survival. The CPR Chicago Project. N Engl J Med (1993) 4.97
Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer. The Cancer and Leukemia Group B. J Natl Cancer Inst (1998) 4.43
The E2F1-3 transcription factors are essential for cellular proliferation. Nature (2001) 4.37
Genomewide association for schizophrenia in the CATIE study: results of stage 1. Mol Psychiatry (2008) 4.14
Excessive CpG island hypermethylation in cancer cell lines versus primary human malignancies. Hum Mol Genet (2001) 3.58
Linkage disequilibrium mapping in isolated populations: the example of Finland revisited. Proc Natl Acad Sci U S A (1998) 3.35
Efficient transfer of highly resolved small DNA fragments from polyacrylamide gels to DBM paper. Gene (1980) 3.30
Expression profiling reveals fundamental biological differences in acute myeloid leukemia with isolated trisomy 8 and normal cytogenetics. Proc Natl Acad Sci U S A (2001) 3.01
Dose: a critical factor in cancer chemotherapy. Am J Med (1980) 2.82
Antiemetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy. N Engl J Med (1975) 2.71
A successful system of scientific data audits for clinical trials. A report from the Cancer and Leukemia Group B. JAMA (1993) 2.60
The nature and control of infections in patients with acute leukemia. Cancer Res (1965) 2.55
Gene expression in papillary thyroid carcinoma reveals highly consistent profiles. Proc Natl Acad Sci U S A (2001) 2.38
Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression. N Engl J Med (1988) 2.23
The phenotypic difference discards sib-pair QTL linkage information. Am J Hum Genet (1997) 2.03
Adjuvant methotrexate and citrovorum-factor treatment of osteogenic sarcoma. N Engl J Med (1974) 2.02
Tumor resistance to alkylating agents conferred by mechanisms operative only in vivo. Science (1990) 1.93
A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2'-deoxyuridine and 5-fluorouracil. Cancer Res (1978) 1.88
Clinical trials with adriamycin. Cancer (1971) 1.86
Spilled gallstones after laparoscopic cholecystectomy. A relevant problem? A retrospective analysis of 10,174 laparoscopic cholecystectomies. Surg Endosc (1998) 1.77
A lesson from Canada: Ontario's health insurance. N Engl J Med (1978) 1.76
Carcinoembryonic antigen: clinical correlation with chemotherapy for metastatic gastrointestinal cancer. Cancer (1974) 1.74
Recombinant human tumor necrosis factor administered as a 24-hour intravenous infusion. A phase I and pharmacologic study. J Natl Cancer Inst (1988) 1.73
Controlled multicenter trial of laparoscopic transabdominal preperitoneal hernioplasty vs Shouldice herniorrhaphy. Early results. Surg Endosc (1996) 1.71
The Polycomb-group gene, extra sex combs, encodes a nuclear member of the WD-40 repeat family. EMBO J (1995) 1.69
Active immunotherapy with B.C.G. for recurrent malignant melanoma. Lancet (1973) 1.66
Complications of laparoscopic cholecystectomy in Switzerland. A prospective 3-year study of 10,174 patients. Swiss Association of Laparoscopic and Thoracoscopic Surgery. Surg Endosc (1998) 1.65
Assembly, annotation, and integration of UNIGENE clusters into the human genome draft. Genome Res (2001) 1.60
Identification of a locus on chromosome 1q44 for familial cold urticaria. Am J Hum Genet (2000) 1.51
Studies of patients in a laminar air flow unit. Cancer (1969) 1.49
Recurrent germline mutation in MSH2 arises frequently de novo. J Med Genet (2000) 1.49
Combination cancer therapy: Presidential address. Cancer Res (1972) 1.47
Improved prognosis of diffuse histiocytic and undifferentiated lymphoma by use of high dose methotrexate alternating with standard agents (M-BACOD). J Clin Oncol (1983) 1.45
Intensive combination chemotherapy and X-irradiation in Hodgkin's disease. Cancer Res (1967) 1.44
Selection bias in clinical trials. J Clin Oncol (1985) 1.42
Complex regulation of early paired expression: initial activation by gap genes and pattern modulation by pair-rule genes. Development (1993) 1.39
Preoperative Nyhus classification of inguinal hernias and type-related individual hernia repair. A case for diagnostic laparoscopy. Surg Laparosc Endosc (1997) 1.39
Influence of intensive asparaginase in the treatment of childhood non-T-cell acute lymphoblastic leukemia. Cancer Res (1983) 1.39
The efficacy and effectiveness of a primary preventive dental programme in non-fluoridated areas of Victoria, Australia. Community Dent Health (1998) 1.39
[Early results of the initial 100 laparoscopic hernia operations under peridural anesthesia]. Schweiz Med Wochenschr (1995) 1.39
Effect of adriamycin on the cell cycle traverse and kinetics of cultured human lymphoblasts. Cancer Res (1976) 1.38
Recombinant human tumor necrosis factor administered as a five-day continuous infusion in cancer patients: phase I toxicity and effects on lipid metabolism. J Clin Oncol (1988) 1.37
Combined cyclophosphamide vincristine, and prednisone therapy of malignant lymphoma. Cancer (1971) 1.37
Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer Institute. Ann Intern Med (1980) 1.37
Clinical pharmacology of 1-beta-d-arabinofuranosyl cytosine. Clin Pharmacol Ther (1972) 1.35
Dose schedule and antitumor studies of arabinosyl cytosine (NSC 63878). Cancer Res (1969) 1.33
Role of murine tumor models in cancer treatment research. Cancer Res (1986) 1.30
Dietary supplement use by women at risk for breast cancer recurrence. The Women's Healthy Eating and Living Study Group. J Am Diet Assoc (1998) 1.29
Studiesof a patient isolator unit and prophylactic antibiotics in cancer chemotherapy. General techniques and preliminary results. Cancer (1968) 1.28
The anticancer agent ellipticine on activation by cytochrome P450 forms covalent DNA adducts. Biochem Pharmacol (2001) 1.27
Combination chemotherapy in advanced Hodgkin's disease. Induction and maintenance of remission. Ann Intern Med (1973) 1.27
The National Cancer Chemotherapy Program. Science (1982) 1.26
Prognostic correlations and response to treatment in advanced metastatic malignant melanoma. Cancer Res (1974) 1.25
The effectiveness of combinations of antileukemic agents in inducing and maintaining remission in children with acute leukemia. Blood (1965) 1.23
Characterization of a human squamous carcinoma cell line resistant to cis-diamminedichloroplatinum(II). Cancer Res (1987) 1.23
double-time is identical to discs overgrown, which is required for cell survival, proliferation and growth arrest in Drosophila imaginal discs. Development (1999) 1.23
The effect of skin homograft rejection on recipient and donor mixed leukocyte cultures. J Exp Med (1965) 1.22
Progress and perspectives in the chemotherapy of acute leukemia. Adv Chemother (1965) 1.22
Cell proliferation in human melanoma. J Clin Invest (1970) 1.21
shaven and sparkling are mutations in separate enhancers of the Drosophila Pax2 homolog. Development (1998) 1.18
Chromogranin A in human hypertension. Influence of heredity. Hypertension (1995) 1.18
Chemotherapy of sarcomas with a combination of adriamycin and dimethyl triazeno imidazole carboxamide. Cancer (1972) 1.18
Osteosarcoma: fifteen years later. N Engl J Med (1985) 1.17
Cyclophosphamide pharmacokinetics: correlation with cardiac toxicity and tumor response. J Clin Oncol (1992) 1.15
Alkylating agents: in vitro studies of cross-resistance patterns in human cell lines. Cancer Res (1986) 1.15
L-dopa: selective toxicity for melanoma cells in vitro. Science (1977) 1.15
Adverse effects of intrathecal methotrexate in children with acute leukemia in remission. Blood (1975) 1.14
Global methylation profiling of lung cancer identifies novel methylated genes. Neoplasia (2001) 1.14
Loss of heterozygosity for chromosome 11 in primary human breast tumors is associated with poor survival after metastasis. Cancer Res (1995) 1.13
A comparison of self-reported dental health attitudes and behavior between selected Japanese and Australian students. J Dent Educ (1997) 1.13
New approaches to cancer chemotherapy with methotrexate. N Engl J Med (1975) 1.12
Chemotherapy of malignant lymphoma with adriamycin. Cancer Res (1973) 1.11
Pharmacokinetics of actinoymcin D in patients with malignant melanoma. Clin Pharmacol Ther (1975) 1.10
High-dose ifosfamide with mesna uroprotection: a phase I study. J Clin Oncol (1990) 1.09
Comparison of three methods of central-nervous-system prophylaxis in childhood acute lymphoblastic leukaemia. Lancet (1980) 1.09
Genetic crossover interference in the human genome. Ann Hum Genet (2001) 1.08
Use of pharmaco-metabonomics for early prediction of acetaminophen-induced hepatotoxicity in humans. Clin Pharmacol Ther (2010) 1.08
Passover: a gene required for synaptic connectivity in the giant fiber system of Drosophila. Cell (1993) 1.07
Catecholamine storage vesicle protein expression in genetic hypertension. Blood Press (1999) 1.07
MSH6 and MSH3 are rarely involved in genetic predisposition to nonpolypotic colon cancer. Cancer Res (2001) 1.06
Prognotic significance of pretreatment proliferative activity in adult acute leukemia. Cancer (1977) 1.06
Orthodontic treatment need of secondary schoolchildren in Heidelberg, Victoria: an epidemiologic study using the Dental Aesthetic Index. Community Dent Health (1994) 1.06
Protected environment-prophylactic antibiotic program in the chemotherapy of acute leukemia. Am J Med Sci (1971) 1.05
Selective incorporation of L-3,4-dihydroxyphenylalanine by S-91 Cloudman melanoma in vitro. Cancer Res (1977) 1.05
RET genotypes comprising specific haplotypes of polymorphic variants predispose to isolated Hirschsprung disease. J Med Genet (2000) 1.05
A phase I clinical and pharmacokinetic study of carboplatin and autologous bone marrow support. J Clin Oncol (1989) 1.04
Nutrient intakes from foods and dietary supplements in women at risk for breast cancer recurrence. The Women's Healthy Eating and Living Study Group. Nutr Cancer (1997) 1.04
Phase II study of topotecan in metastatic non-small-cell lung cancer. J Clin Oncol (1994) 1.03
The validity of the CPITN scoring and presentation method for measuring periodontal conditions. J Clin Periodontol (1994) 1.03
High dose methotrexate with leucovorin rescue. Rationale and spectrum of antitumor activity. Am J Med (1980) 1.02
Feasibility of a randomized trial of a high-vegetable diet to prevent breast cancer recurrence. Nutr Cancer (1997) 1.02
Aberrant promoter methylation of previously unidentified target genes is a common abnormality in medulloblastomas--implications for tumor biology and potential clinical utility. Oncogene (2001) 1.02
Novel methylation targets in de novo acute myeloid leukemia with prevalence of chromosome 11 loci. Blood (2001) 1.01
Neoadjuvant chemotherapy in marginally resectable stage III M0 non-small cell lung cancer: long-term follow-up in 41 patients. J Surg Oncol (1989) 1.01
Pharmacologic studies of the antitumor agent 5-(dimethyltriazeno)imidazole-4-carboxamide. Cancer Res (1968) 1.01
Alkylating agent resistance: in vitro studies with human cell lines. Proc Natl Acad Sci U S A (1985) 1.01
Development of methotrexate resistance in a human squamous cell carcinoma of the head and neck in culture. Proc Natl Acad Sci U S A (1984) 1.01
Post-surgical follow-up (by ELISA and immunoblotting) of cured versus non-cured cystic echinococcosis in young patients. Parasitology (2007) 1.01